Home > Compound List > Product Information
Estradiol_Molecular_structure_CAS_50-28-2)
Click picture or here to close

Estradiol

Catalog No. Bio-0812 Name InterBioScreen
CAS Number 50-28-2 Website http://www.ibscreen.com
M. F. C18H24O2 Telephone +7 49652 40091
M. W. 272.38196 Fax
Purity Email screen@ibscreen.chg.ru
Storage Chembase ID: 663

SYNONYMS

IUPAC name
(1S,10R,11S,14S,15S)-15-methyltetracyclo[8.7.0.02,7.011,15]heptadeca-2(7),3,5-triene-5,14-diol
IUPAC Traditional name
(1S,10R,11S,14S,15S)-15-methyltetracyclo[8.7.0.02,7.011,15]heptadeca-2(7),3,5-triene-5,14-diol

DATABASE IDS

CAS Number 50-28-2

PROPERTIES

Application(s) The most potent of the natural estrogens
Application(s) Estradiol (and its semisynthetic esters) are used in estrogen replacement therapy
Biological Source Isol. from ovaries and pregnancy urine. Sex pheromone for mallard ducks
Mechanism of Action Estradiol enters cells freely and interacts with a cytoplasmic target cell receptor.
Mechanism of Action When the estrogen receptor has bound its ligand it can enter the nucleus of the target cell, and regulate gene transcription which leads to formation of messenger RNA.
Mechanism of Action The mRNA interacts with ribosomes to produce specific proteins that express the effect of estradiol upon the target cell.

DETAILS

REFERENCES

  • Aldrich Library of FT-IR Spectra, 1st edn., 1985, 2, 1055C, (ir)
  • Aldrich Library of 13C and 1H FT NMR Spectra, 1992, 3, 565A; 589B; 600B, (nmr)
  • Marker, R.E., J.A.C.S., 1938, 60, 2927, (synth)
  • Miki, T. et al., Proc. Chem. Soc., London, 1963, 139, (synth)
  • Ohrt, J.M. et al., Acta Cryst., 1964, 17, 1611, (cryst struct, derivs)
  • Gibson, H. et al., Tet. Lett., 1966, 2321, (synth)
  • Tsukuda, Y. et al., J.C.S.(B), 1968, 1387, (cryst struct)
  • Wittstruck, T.A. et al., J.O.C., 1973, 38, 1542, (cmr)
  • Ponold, K. et al., Pharmazie, 1973, 28, 371; 1977, 32, 598; 1979, 34, 2050, (STS 153)
  • Busetta, B. et al., Acta Cryst. B, 1976, 32, 1290, (cryst struct)
  • Eder, U. et al., Chem. Ber., 1976, 109, 2948, (synth)
  • IARC Monog., 1979, 21, 279, (tox, rev)
  • Quinkert, G. et al., Annalen, 1981, 2335; 1982, 1999, (synth)
  • Hylarides, M.D. et al., J.O.C., 1984, 49, 2744, (synth)
  • Larner, J.M. et al., Endocrinology (Baltimore), 1985, 117, 1209, (metab)
  • Salole, E.G. et al., Anal. Profiles Drug Subst., 1986, 15, 283, (rev)
  • Schneider, G. et al., Annalen, 1988, 679, (3-Me ether, synth, pmr, cmr, ir)
  • Negwer, M., Organic-Chemical Drugs and their Synonyms, 7th edn., Akademie-Verlag, 1994, 6627, (synonyms)
  • Collins, M.A. et al., Tet. Lett., 1995, 36, 4467, (synth)
  • Martindale, The Extra Pharmacopoeia, 32nd edn., Pharmaceutical Press, 1999, 1455
  • Lewis, R.J., Sax's Dangerous Properties of Industrial Materials, 8th edn., Van Nostrand Reinhold, 1992, BFV325; EDO000; EDP000; EDR000; EDS100; DAZ115; EDO500; EDR500